Poring over pores: α-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Inactivation of alpha-hemolysin limits the virulence of S. aureus [108–114].”
From Metal ion acquisition in Staphylococcus aureus: overcoming nutritional immunity (2012) · cites this paper as [110]
In the citing paper
“The ability of staphylococci to acquire heme and hemoproteins in vivo is facilitated by lysis of host erythrocytes by pore-forming toxins such as alpha-hemolysin (encoded by hla) (Fig. 1).”
From Metal ion acquisition in Staphylococcus aureus: overcoming nutritional immunity (2012) · cites this paper as [110]
Citations
Cites
Staphylococcus aureus Infections
Lowy, F. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808203390806 · Cited by 6,005
Gillet, Y., Issartel, B., Vanhems, P., Fournet, J.-C., Lina, G., Bes, M., Vandenesch, F., Piémont, Y., Brousse, N., Floret, D., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07877-7 · Cited by 1,514
Genome and virulence determinants of high virulence community-acquired MRSA
Baba, T., Takeuchi, F., Kuroda, M., Yuzawa, H., Aoki, K.-I., Oguchi, A., Nagai, Y., Iwama, N., Asano, K., Naimi, T., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08713-5 · Cited by 1,370
Staphylococcus aureus Panton-Valentine Leukocidin Causes Necrotizing Pneumonia
Labandeira-Rey, M., Couzon, F., Boisset, S., Brown, E. L., Bes, M., Benito, Y., Barbu, E. M., Vazquez, V., Höök, M., Etienne, J., et al. (2007) · Science · doi:10.1126/science.1137165 · Cited by 709
Voyich, J. M., Otto, M., Mathema, B., Braughton, K. R., Whitney, A. R., Welty, D., Long, R. D., Dorward, D. W., Gardner, D. J., Lina, G., et al. (2006) · The Journal of Infectious Diseases · doi:10.1086/509506 · Cited by 565
Self-citationSurface Proteins and Exotoxins Are Required for the Pathogenesis of Staphylococcus aureus Pneumonia
Wardenburg, J. B., Patel, R. J., & Schneewind, O. (2007) · Infection and Immunity · doi:10.1128/iai.01313-06 · Cited by 348
Self-citationKaneko, J., Kimura, T., Narita, S., Tomita, T., & Kamio, Y. (1998) · Gene · doi:10.1016/s0378-1119(98)00278-9 · Cited by 231
Gouaux, E., Hobaugh, M., & Song, L. (1997) · Protein Science · doi:10.1002/pro.5560061216 · Cited by 119
Research works printed but not linked: 1
- Gladstone, G.P. & van Heyningen, W.E. Br. J. Exp. Pathol. 38, 123–137 (1957).
Cited by
Items 101–200 of 496
Quave, C. L., Lyles, J. T., Kavanaugh, J. S., Nelson, K., Parlet, C. P., Crosby, H. A., Heilmann, K. P., & Horswill, A. R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136486 · Cited by 126
Improved understanding of factors driving methicillin-resistant Staphylococcus aureus epidemic waves
Otto, M. J., & Chatterjee (2013) · Clinical Epidemiology · doi:10.2147/clep.s37071 · Cited by 136
Self-citationPrevention and Treatment ofStaphylococcus aureusPneumonia with a β-Cyclodextrin Derivative
Ragle, B. E., Karginov, V. A., & Wardenburg, J. B. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00973-09 · Cited by 127
Kane, T., Carothers, K. E., & Lee, S. W. (2018) · Current Drug Targets · doi:10.2174/1389450117666161128123536 · Cited by 114
Biosynthesis of Peptide Signals in Gram-Positive Bacteria
Thoendel, M., & Horswill, A. R. (2010) · Advances in applied microbiology · doi:10.1016/s0065-2164(10)71004-2 · Cited by 110
Wall teichoic acids mediate increased virulence in Staphylococcus aureus
Wanner, S., Schade, J., Keinhörster, D., Weller, N., George, S. E., Kull, L., Bauer, J., Grau, T., Winstel, V., Stoy, H., et al. (2017) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.257 · Cited by 117
The role of Staphylococcus aureus quorum sensing in cutaneous and systemic infections
Yamazaki, Y., Ito, T., Tamai, M., Nakagawa, S., & Nakamura, Y. (2024) · Inflammation and Regeneration · doi:10.1186/s41232-024-00323-8 · Cited by 110
Tseng, C. W., Kyme, P. A., Low, J., Rocha, M. A., Alsabeh, R., Miller, L. G., Otto, M. J., Arditi, M., Diep, B. A., Nizet, V., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006387 · Cited by 104
Self-citationBartlett, A. H., Foster, T. J., Hayashida, A., & Park, P. W. (2008) · The Journal of Infectious Diseases · doi:10.1086/592758 · Cited by 101
“Of these, -toxin [13–15]”
Das, S., Lindemann, C., Young, B., Müller, J., Oesterreich, B., Ternette, N., Winkler, A.-C., Paprotka, K., Reinhardt, R., Förstner, K. U., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1520255113 · Cited by 112
Tong, S. Y. C., Chen, L. F., & Fowler, V. G. (2011) · Seminars in Immunopathology · doi:10.1007/s00281-011-0300-x · Cited by 122
Defres, S., Marwick, C., & Nathwani, D. (2009) · European Respiratory Journal · doi:10.1183/09031936.00122309 · Cited by 113
Virulence attributes of successful methicillin-resistant Staphylococcus aureus lineages
Jiang, J.-H., Cameron, D. R., Nethercott, C., Aires-de-Sousa, M., & Peleg, A. Y. (2023) · Clinical Microbiology Reviews · doi:10.1128/cmr.00148-22 · Cited by 92
Mrak, L. N., Zielinska, A. K., Beenken, K. E., Mrak, I. N., Atwood, D. N., Griffin, L. M., Lee, C. Y., & Smeltzer, M. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038453 · Cited by 89
Foletti, D. L., Strop, P., Shaughnessy, L., Hasa-Moreno, A., Casas, M. G., Russell, M., Bee, C., Wu, S., Pham, A. T., Zeng, Z., et al. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.02.008 · Cited by 106
Role of Phenol-Soluble Modulins in Formation of Staphylococcus aureus Biofilms in Synovial Fluid
Dastgheyb, S., Villaruz, A. E., LE, K. Y., Tan, V. Y., Duong, A. C., Chatterjee, S. S., Cheung, G. Y. C., Joo, H., Hickok, N. J., & Otto, M. J. (2015) · Infection and Immunity · doi:10.1128/iai.00394-15 · Cited by 104
Self-citationRauch, S., DeDent, A. C., Kim, H. K., Bubeck Wardenburg, J., Missiakas, D. M., & Schneewind, O. (2012) · Infection and Immunity · doi:10.1128/iai.00442-12 · Cited by 95
“In contrast, MRSA MW2, a clinical isolate associated with skin and soft tissue infections, expresses much less toxin than either Newman or USA300 LAC (6).”
BackgroundSelf-citationNovel Inhibitors of Staphylococcus aureus Virulence Gene Expression and Biofilm Formation
Ma, Y., Xu, Y., Yestrepsky, B. D., Sorenson, R. J., Chen, M., Larsen, S. D., & Sun, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047255 · Cited by 100
“SPA, Hla and PSMs are virulence factors [33,58–62] and sspB plays important roles in staphylococcus evasion and resistance to host defense [63].”
BackgroundChua, K. Y. L., Seemann, T., Harrison, P. F., Monagle, S., Korman, T. M., Johnson, P. D. R., Coombs, G. W., Howden, B. O., Davies, J. K., Howden, B. P., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025887 · Cited by 92
Boakes, E., Kearns, A. M., Ganner, M., Perry, C., Hill, R. L., & Ellington, M. J. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.01917-10 · Cited by 85
A Postinfluenza Model of Staphylococcus aureus Pneumonia
Lee, M., Arrecubieta, C., Martin, F. J., Prince, A., Borczuk, A. C., & Lowy, F. D. (2010) · The Journal of Infectious Diseases · doi:10.1086/650204 · Cited by 90
Villaruz, A. E., Wardenburg, J. B., Khan, B. A., Whitney, A. R., Sturdevant, D. E., Gardner, D. J., DeLeo, F. R., & Otto, M. (2009) · The Journal of Infectious Diseases · doi:10.1086/604728 · Cited by 87
Self-citationDiep, B. A., Afasizheva, A., Le, H. N., Kajikawa, O., Matute‐Bello, G., Tkaczyk, C., Sellman, B. R., Badiou, C., Lina, G., & Chambers, H. F. “. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit129 · Cited by 90
“The hypervirulence phenotype of USA300, especially in the context of pneumonia, has been shown in animal models to be due in part to its hyperproduction of two potent staphylococcal toxins, Panton-Valentine leukocidin (PVL) and alpha-hemolysin (Hla) [23, 24], with the former toxin being epidemiologically linked to let…”
BackgroundShukla, S. K., Karow, M. E., Brady, J. M., Stemper, M. E., Kislow, J., Moore, N., Wroblewski, K., Chyou, P., Warshauer, D. M., Reed, K. D., et al. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.00657-10 · Cited by 104
Wang, J., Zhou, X., Li, W., Deng, X., Deng, Y., & Niu, X. (2016) · Scientific Reports · doi:10.1038/srep28254 · Cited by 89
Therapeutic Potential of Polyphenols from Epilobium Angustifolium (Fireweed)
Schepetkin, I. A., Ramstead, A. G., Kirpotina, L. N., Voyich, J. M., Jutila, M. A., & Quinn, M. T. (2016) · Phytotherapy Research · doi:10.1002/ptr.5648 · Cited by 88
“Bubeck Wardenburg J, Bae T, Otto M, Deleo FR, Schneewind O. 2007.”
BackgroundEvolution of hypervirulence by a MRSA clone through acquisition of a transposable element
Benson, M. A., Ohneck, E. A., Ryan, C., Alonzo, F., Smith, H., Narechania, A., Kolokotronis, S., Satola, S. W., Uhlemann, A., Sebra, R., et al. (2014) · Molecular Microbiology · doi:10.1111/mmi.12682 · Cited by 89
“In addition, this toxin is involved in the pathogenesis of USA300 (Bubeck Wardenburg et al., 2007; Kennedy et al., 2010).”
BackgroundAntibodies in infectious diseases: polyclonals, monoclonals and niche biotechnology
Berry, J. D., & Gaudet, R. G. (2011) · New Biotechnology · doi:10.1016/j.nbt.2011.03.018 · Cited by 100
Zivkovic, A., Sharif, O., Stich, K., Doninger, B., Biaggio, M., Colinge, J., Bilban, M., Mesteri, I., Hazemi, P., Lemmens‐Gruber, R., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001665 · Cited by 89
“aureus strains and failed to show any harmful effects of PVL (55, 56), others that used clinical isolates and isogenic strains carrying PVL, as well as purified PVL, clearly demonstrated the tissue-damaging properties of PVL and were able to mimic the necrotizing pneumonia observed in humans (57).”
Novel targeted immunotherapy approaches for staphylococcal infection
Otto, M. J. (2010) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2010.495115 · Cited by 93
Self-citationCameron, D. R., Howden, B. P., & Peleg, A. Y. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir473 · Cited by 81
Quorum Sensing as Antivirulence Target in Cystic Fibrosis Pathogens
Scoffone, V. C., Trespidi, G., Chiarelli, L. R., Barbieri, G., & Buroni, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081838 · Cited by 80
“On th other h d, the upregula ion of Agr enhances the production of virulence factors important for t progression of many st phylococcal diseases, including pneumonia [50], endocarditis [51], septic arthritis, and osteomyelitis [52,53], and skin and soft tissue infections [54].”
BackgroundTromp, A. T., van Gent, M., Abrial, P., Martin, A., Jansen, J. P., de Haas, C. J. C., van Kessel, K. P. M., Bardoel, B. W., Kruse, E. M., Bourdonnay, E., et al. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0159-x · Cited by 84
The adherens junctions control susceptibility to Staphylococcus aureus α-toxin
Popov, L. M., Marceau, C. D., Starkl, P. M., Lumb, J. H., Shah, J., Guerrera, D., Cooper, R. L., Merakou, C., Bouley, D. M., Meng, W., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1510265112 · Cited by 83
“The relevance of PLEKHA7 for determining the outcome of in vivo MRSA bacterial infections was demonstrated in two relevant infection models, a self-resolving skin infection (37) and a lethal pneumonia (7, 8).”
BackgroundMethodAn update on community-associated MRSA virulence
Kobayashi, S. D., & DeLeo, F. R. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.07.009 · Cited by 92
Self-citationRecurrent furunculosis: a review of the literature
Demos, M., McLeod, M. P., & Nouri, K. (2012) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2012.11151.x · Cited by 81
Löffler, B., Niemann, S., Ehrhardt, C., Horn, D., Lanckohr, C., Lina, G., Ludwig, S., & Peters, G. (2013) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2013.827891 · Cited by 81
Hongo, I., Baba, T., Oishi, K., Morimoto, Y., Ito, T., & Hiramatsu, K. (2009) · The Journal of Infectious Diseases · doi:10.1086/605332 · Cited by 80
Staphylococcus aureus evasion of innate antimicrobial defense.
Kraus, D., & Peschel, A. (2008) · Future Microbiology · doi:10.2217/17460913.3.4.437 · Cited by 82
Staphylococcus aureus α-toxin modulates skin host response to viral infection
Bin, L., Kim, B. E., Brauweiler, A., Goleva, E., Streib, J., Ji, Y., Schlievert, P. M., & Leung, D. Y. M. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.06.019 · Cited by 78
Blättner, S., Das, S., Paprotka, K., Eilers, U., Krischke, M., Kretschmer, D., Remmele, C. W., Dittrich, M. T., Müller, T., Schuelein‐Voelk, C., et al. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005857 · Cited by 84
Human OTULIN haploinsufficiency impairs cell-intrinsic immunity to staphylococcal α-toxin
Spaan, A. N., Neehus, A., Laplantine, E., Staels, F., Ogishi, M., Seeleuthner, Y., Rapaport, F., Lacey, K. A., Nieuwenhove, E. V., Chrabieh, M., et al. (2022) · Science · doi:10.1126/science.abm6380 · Cited by 83
Schreiner, J., Kretschmer, D., Klenk, J., Otto, M. J., Bühring, H., Stevanović, S., Wang, J., Beer‐Hammer, S., Peschel, A., & Autenrieth, S. E. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202563 · Cited by 85
Self-citationCommunity-associated methicillin-resistant Staphylococcus aureus immune evasion and virulence
Graves, S. F., Kobayashi, S. D., & DeLeo, F. R. (2010) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0573-x · Cited by 95
Self-citationMonaco, M., Pedroni, P., Sanchini, A., Bonomini, A., Indelicato, A., & Pantosti, A. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-258 · Cited by 77
Hua, L., Cohen, T. S., Shi, Y., Datta, V., Hilliard, J. J., Tkaczyk, C., Suzich, J., Stover, C. K., & Sellman, B. R. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00510-15 · Cited by 75
Chen, C., Unger, C., Hoffmann, W. H., Lindsay, J. A., Huang, Y., & Götz, F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063210 · Cited by 79
Ferreira, F. A., de Souza, R. R., Moraes, B. D. S., Ferreira, A. M. D. A., Américo, M. A., Fracalanzza, S. E. L., Couceiro, J. N. D. S. S., & Figueiredo, A. M. S. (2013) · BMC Microbiology · doi:10.1186/1471-2180-13-93 · Cited by 75
An Eye on Staphylococcus aureus Toxins: Roles in Ocular Damage and Inflammation
Astley, R., Miller, F. C., Mursalin, M. H., Coburn, P. S., & Callegan, M. C. (2019) · Toxins · doi:10.3390/toxins11060356 · Cited by 87
“α-toxin has been widely studied for its role in the pathogenesis of central nervous system infections [65], endocarditis [66], endophthalmitis [52], keratitis [55,67,68], mastitis [69], pneumonia [70,71], sepsis [72,73], and skin and soft tissue infections [74,75].”
BackgroundLin, S. X. W., & Balthasar, J. P. (2018) · Antibodies · doi:10.3390/antib7010005 · Cited by 74
Yoong, P., & Pier, G. B. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910344107 · Cited by 74
Nguyen, M., Uebele, J., Kumari, N., Nakayama, H., Peter, L., Tichá, O., Woischnig, A.-K., Schmaler, M., Khanna, N., Dohmae, N., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-02234-4 · Cited by 79
Soong, G., Martin, F. J., Chun, J., Cohen, T. S., Ahn, D. S., & Prince, A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.295386 · Cited by 73
Tissue-Specific Patterning of Host Innate Immune Responses by Staphylococcus aureus α-Toxin
Becker, R. E. N., Berube, B. J., Sampedro, G. R., DeDent, A. C., & Wardenburg, J. B. (2014) · Journal of Innate Immunity · doi:10.1159/000360006 · Cited by 76
Lobo, L. J., Reed, K. D., & Wunderink, R. G. (2010) · CHEST Journal · doi:10.1378/chest.09-1562 · Cited by 80
Montgomery, C. P., Boyle-Vavra, S., & Daum, R. S. (2009) · Infection and Immunity · doi:10.1128/iai.00256-09 · Cited by 74
Moriarty, T. F., Grainger, D. W., & Richards, R. G. (2014) · European Cells and Materials · doi:10.22203/ecm.v028a09 · Cited by 80
Cole, J., Aberdein, J., Jubrail, J., & Dockrell, D. H. (2014) · Advances in microbial physiology/Advances in Microbial Physiology · doi:10.1016/bs.ampbs.2014.08.004 · Cited by 81
Pseudomonas aeruginosa: breaking down barriers
Berube, B. J., Rangel, S. M., & Hauser, A. R. (2015) · Current Genetics · doi:10.1007/s00294-015-0522-x · Cited by 79
Chi, C., Lin, C., Liao, I., Yao, Y., Shen, F.-C., Liu, H., & Lin, C. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit445 · Cited by 73
Innate Immune Signaling Activated by MDR Bacteria in the Airway
Parker, D., Ahn, D. S., Cohen, T. S., & Prince, A. S. (2015) · Physiological Reviews · doi:10.1152/physrev.00009.2015 · Cited by 75
Immunity to Staphylococcus aureus secreted proteins protects rabbits from serious illnesses
Spaulding, A. R., Lin, Y., Merriman, J. A., Brosnahan, A. J., Peterson, M. L., & Schlievert, P. M. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.05.067 · Cited by 70
Staphylococcal Superantigens Cause Lethal Pulmonary Disease in Rabbits
Strandberg, K. L., Rotschafer, J. H., Vetter, S. M., Buonpane, R. A., Kranz, D. M., & Schlievert, P. M. (2010) · The Journal of Infectious Diseases · doi:10.1086/657156 · Cited by 70
Tseng, C. W., Biancotti, J. C., Berg, B. L., Gate, D., Kolar, S. L., Müller, S., Rodriguez, M. D., Rezai-Zadeh, K., Fan, X., Beenhouwer, D. O., et al. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1005292 · Cited by 67
Diep, B. A., Le, V. T. M., Visram, Z., Rouha, H., Stulik, L., Dip, E. C., Nagy, G., & Nagy, E. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01213-16 · Cited by 68
Hermos, C., Yoong, P., & Pier, G. B. (2010) · Clinical Infectious Diseases · doi:10.1086/656742 · Cited by 68
Montgomery, C. P., & Daum, R. S. (2009) · Infection and Immunity · doi:10.1128/iai.00021-09 · Cited by 68
Humanized Mice Exhibit Increased Susceptibility to Staphylococcus aureus Pneumonia
Prince, A., Wang, H., Kitur, K., & Parker, D. (2016) · Journal of Infectious Diseases · doi:10.1093/infdis/jiw425 · Cited by 60
Wang, J., Zhou, X., Liu, S., Li, G., Shi, L., Dong, J., Li, W., Deng, X., & Niu, X. (2015) · Journal of Applied Microbiology · doi:10.1111/jam.12743 · Cited by 66
“The important role of Hla in the pathogenesis of Staph. aureus infections has been extensively investigated in the infection of the cornea, lung, endocardium and mammary gland (Bramley et al. 1989; OCallaghan et al. 1997; Wardenburg et al. 2007).”
BackgroundMontgomery, C. P., Boyle-Vavra, S., Roux, A., Ebine, K., Sonenshein, A. L., & Daum, R. S. (2012) · Infection and Immunity · doi:10.1128/iai.06172-11 · Cited by 59
Population Structure of Staphylococcus aureus from Remote African Babongo Pygmies
Schaumburg, F., Köck, R., Friedrich, A. W., Soulanoudjingar, S., Ngoa, U. A., von Eiff, C., Issifou, S., Kremsner, P. G., Herrmann, M., Peters, G., et al. (2011) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0001150 · Cited by 62
Community-Associated Methicillin-Resistant Staphylococcus aureus Case Studies
Sowash, M. G., & Uhlemann, A. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-664-1_2 · Cited by 72
“A sia M al ay si a [ 1 43 ] 20 06 –2 00 7 In va si ve is ol at es fr om a la rg e”
BackgroundCommunity-associated meticillin-resistant Staphylococcus aureus
Hsu, L. Y., Wijaya, L., & Koh, T. H. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61369-4 · Cited by 65
Tabor, D. E., Yu, L., Mok, H., Tkaczyk, C., Sellman, B. R., Wu, Y., Oganesyan, V., Slidel, T. W. F., Jafri, H. S., McCarthy, M., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00357-16 · Cited by 67
Divyakolu, S., Chikkala, R., Ratnakar, K. S., & Sritharan, V. (2019) · Advances in Infectious Diseases · doi:10.4236/aid.2019.92007 · Cited by 64
“aureus/MRSA infections and an increase in the incidence of severe pneumonia [41].”
BackgroundEvaluation of Staphylococcus aureus virulence factors using a silkworm model
Miyazaki, S., Matsumoto, Y., Sekimizu, K., & Kaito, C. (2011) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2011.02439.x · Cited by 63
Innate Sex Bias of Staphylococcus aureus Skin Infection Is Driven by α-Hemolysin
Castleman, M. J., Pokhrel, S., Triplett, K. D., Kusewitt, D. F., Elmore, B. O., Joyner, J. A., Femling, J., Sharma, G., Hathaway, H. J., Prossnitz, E. R., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700810 · Cited by 67
Jappe, U., Heuck, D., Strommenger, B., Wendt, C., Werner, G., Altmann, D., & Witte, W. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.133 · Cited by 61
Biogeography and Virulence of Staphylococcus aureus
Fan, J., Shu, M., Zhang, G., Zhou, W. L., Jiang, Y., Zhu, Y., Chen, G., Peacock, S. J., Wan, C., Pan, W., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006216 · Cited by 68
Lorenz, U., Lorenz, B., Schmitter, T., Streker, K., Erck, C., Wehland, J., Nickel, J., Zimmermann, B., & Ohlsen, K. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01144-10 · Cited by 59
Host Nitric Oxide Disrupts Microbial Cell-to-Cell Communication to Inhibit Staphylococcal Virulence
Urbano, R., Karlinsey, J. E., Libby, S. J., Doulias, P., Ischiropoulos, H., Warheit-Niemi, H. I., Liggitt, D. H., Horswill, A. R., & Fang, F. C. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.04.001 · Cited by 64
Qiu, J., Wang, D., Zhang, Y., Dong, J., Wang, J., & Niu, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080197 · Cited by 58
Shambat, S. M., Chen, P., Hoang, A. T. N., Bergsten, H., Vandenesch, F., Siemens, N., Lina, G., Monk, I. R., Foster, T. J., Arakere, G., et al. (2015) · Disease Models & Mechanisms · doi:10.1242/dmm.021923 · Cited by 58
Stelzner, K., Boyny, A., Hertlein, T., Sroka, A., Moldovan, A., Paprotka, K., Kessie, D. K., Mehling, H., Potempa, J., Ohlsen, K., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009874 · Cited by 62
The psm α Locus Regulates Production of Staphylococcus aureus Alpha-Toxin during Infection
Berube, B. J., Sampedro, G. R., Otto, M. J., & Wardenburg, J. B. (2014) · Infection and Immunity · doi:10.1128/iai.00089-14 · Cited by 57
Self-citationEnzymatic properties of Staphylococcus aureus adenosine synthase (AdsA)
Thammavongsa, V., Schneewind, O., & Missiakas, D. M. (2011) · BMC Biochemistry · doi:10.1186/1471-2091-12-56 · Cited by 57
“These include several toxins that are known for their detrimental effects on host cells [5,6], in particular cells of the immune system [7,8].”
BackgroundSelf-citationStaphylococcus aureus , Antibiotic Resistance, and the Interaction with Human Neutrophils
Rungelrath, V., & DeLeo, F. R. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8127 · Cited by 67
Self-citationZakour, N. L. B., Guinane, C. M., & Fitzgerald, J. R. (2008) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2008.01384.x · Cited by 66
Inactivation of staphylococcal virulence factors using a light-activated antimicrobial agent
Tubby, S., Wilson, M., & Nair, S. P. (2009) · BMC Microbiology · doi:10.1186/1471-2180-9-211 · Cited by 55
Identification of the Staphylococcus aureus vfrAB Operon, a Novel Virulence Factor Regulatory Locus
Bose, J. L., Daly, S. M., Hall, P. R., & Bayles, K. W. (2014) · Infection and Immunity · doi:10.1128/iai.01655-13 · Cited by 55
Lysis of human neutrophils by community-associated methicillin-resistant Staphylococcus aureus
Greenlee‐Wacker, M. C., Kremserová, S., & Nauseef, W. M. (2017) · Blood · doi:10.1182/blood-2017-02-766253 · Cited by 59
Tavares, A. F. N., Nielsen, J. B., Boye, K., Rohde, S. M., Paulo, A. C., Westh, H., Schønning, K., de LENCASTRE, H., & Miragaia, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098634 · Cited by 63
Yoong, P., & Pier, G. B. (2012) · Infection and Immunity · doi:10.1128/iai.06360-11 · Cited by 56
“Others report no difference in outcomes in mouse pneumonia models comparing WT and pvl strains (3, 5), although mouse white blood cells appear to be resistant to the cytotoxic effects of PVL (11).”
BackgroundChua, K., Monk, I. R., Lin, Y.-H., Seemann, T., Tuck, K. L., Porter, J. L., Stepnell, J., Coombs, G. W., Davies, J. K., Stinear, T. P., et al. (2014) · BMC Microbiology · doi:10.1186/1471-2180-14-31 · Cited by 59
Jiang, Q., Jin, Z., & Sun, B. (2018) · Applied and Environmental Microbiology · doi:10.1128/aem.01008-18 · Cited by 46
“Staphylococcus aureus is a human and animal pathogen that can cause various bacterial infections, including relatively benign and fatal systemic diseases (1, 2).”
BackgroundYamaguchi, T., Nakamura, I., Sato, T., Ono, D., Sato, A., Sonoda, S., Aoki, K., Miura, Y., Koyama, S., Tamai, K., et al. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.02272-21 · Cited by 52
Sharma‐Kuinkel, B. K., Wu, Y., Tabor, D. E., Mok, H., Sellman, B. R., Jenkins, A. L., Yu, L., Jafri, H. S., Rude, T. H., Ruffin, F., et al. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.02023-14 · Cited by 53
CD4+ T Cells Promote the Pathogenesis of Staphylococcus aureus Pneumonia
Parker, D., Ryan, C., Alonzo, F., Torres, V. J., Planet, P. J., & Prince, A. S. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu525 · Cited by 56
“ponents are involved [7–11].”
Humanized Mouse Models of Staphylococcus aureus Infection
Parker, D. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00512 · Cited by 56
Soleimani, M., & Habibi-Pirkoohi, M. (2017) · PubMed Central · Cited by 52
Metadata
- Authors
- Bubeck Wardenburg, J., Bae, T., Otto, M., DeLeo, F. R., & Schneewind, O.
- Affiliations
- Indiana University Northwest (US)
- National Institutes of Health (US)
- University of Chicago (US)
- Venue
- Nature Medicine
- Published
- 2007-12
- Volume
- 13
- Issue
- 12
- Pages
- 1405-1406
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2044206614
- Cited by
- 492
- References
- 8
- Citations by year
- 2026: 6 · 2025: 6 · 2024: 17 · 2023: 20 · 2022: 11 · 2021: 15 · 2020: 14 · 2019: 23 · 2018: 27 · 2017: 18 · 2016: 24 · 2015: 32 · 2014: 41 · 2013: 48 · 2012: 42
- FWCI
- 23.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Infectious Diseases › Streptococcal Infections and Treatments
- Health Sciences › Medicine › Epidemiology › Pneumonia and Respiratory Infections
- Keywords
- Staphylococcus aureus pneumonia, alpha-hemolysin, Panton-Valentine leukocidin, cytotoxin, epithelial lining fluid, lung epithelial barrier, pneumococcal pneumonia, monoclonal antibodies, G protein-coupled estrogen receptor, sensory deprivation
- MeSH terms
- Alleles, Animals, Bacterial Toxins, Exotoxins, Hemolysin Proteins, Humans, Leukocidins, Mice, Inbred C57BL, Models, Biological, Pneumonia, Staphylococcal, Staphylococcus aureus, Virulence, Drug Resistance, Bacterial, Escherichia coli Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.